Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share (JANX)

Q: What does CUSIP 47103J105 represent in this 13F holders report?

CUSIP 47103J105 is the security identifier for JANX - Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held JANX - Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q2 2025?

169 institutional investors reported JANX - Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 47103J105

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 65,389,958
Total 13F value: $1,510,522,459
Share change: -970,885
Put/Call ratio: 75%
SEC-reported price per share: $23.10
Number of holders: 169
Value change: -$28,053,981
Number of buys: 94
Number of sells: 75
Shares outstanding: 60,419,303

Security key

47103J105

Report period

Q2 2025

Institutions

169

Top holders

JANX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Janux Therapeutics, Inc. SEC filings Janux Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 47103J105

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of JANX - Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RA CAPITAL MANAGEMENT, L.P.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

3/15

Latest evidence

30 Jun 2025

13D/G 13F 3/4/5 Lead comparable stake: 20% 12 rows are not safely comparable across share classes. 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 20%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.

Comparable ownership Top 3

RA CAPITAL MANAGEMENT, L.P. 20%

Paradigm Biocapital Advisors LP 4.9%

Adage Capital Management, L.P. 4.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RA CAPITAL MANAGEMENT, L.P.	13D/G 13F Company 13D/G 13F	20% Reported 13D/G · 06 Mar 2025	$383,922,060 11,971,377 shares	$0	06 Mar 2025
Paradigm Biocapital Advisors LP	13F 13D/G Company 13F 13D/G	4.9% Reported 13D/G · 30 Jun 2025	$89,907,543 3,329,909 shares	—	31 Mar 2025
Adage Capital Management, L.P.	13D/G 13D/G	4.3% Reported 13D/G · 30 Jun 2025	$63,503,750 2,525,000 shares	-$13,499,262	30 Jun 2025
Avalon Ventures XI, L.P.	3/4/5 10%+ Owner 3/4/5	— mixed-class rows	$346,500,118 7,383,837 shares mixed-class rows	—	16 Oct 2024
Jay B. Lichter	3/4/5 10%+ Owner 3/4/5	— mixed-class rows	$293,610,026 6,568,498 shares mixed-class rows	—	13 Sep 2024
Bregua Corp	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$22,008,098 3,749,250 shares	—	15 Jun 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

169

65,389,958

Rows available

169

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

179

Q2 2025 holders

169

Holder diff

-10

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 value	Q2 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend